Search clinical trials for: GAD-alum (Diamyd) 40 μg/mL

Total 16 results

Linkoeping University
Diamyd Medical AB

Completed

Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes

Diabetes Mellitus, Type 1

Sweden
Oslo University Hospital

Terminated

Diabetes Virus Detection Project, Intervention With GAD-alum (DiViD)

Enterovirus Infections | Diabetes, Type I | Autoimmunity

Norway
Lund University
Region Skane

Completed

Diabetes Prevention - Immune Tolerance (DIAPREV-IT)

Type 1 Diabetes | Prediabetes

Sweden
Lund University
Region Skane

Terminated

Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies (DiAPREV-IT2)

Diabetes Mellitus, Type 1 | Prediabetic State

Sweden
Diamyd Therapeutics AB

Terminated

A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)

Type 1 Diabetes Mellitus

France, Germany, Finland, Italy, Netherlands, Slovenia, Spain, Sweden, United Kingdom
National Institute of Diabetes and Digestive and...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects (TN08)

Type 1 Diabetes Mellitus

United States, Canada
Johnny Ludvigsson
Ostergotland County Council, Sweden; Diamyd Medical AB; Swedish Child Diabetes...

Completed

GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1) (DIAGNODE)

Diabetes Mellitus, Type 1

Sweden
Johnny Ludvigsson
Diamyd Medical AB; Swedish Child Diabetes Foundation; The Research Council of...

Completed

DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen

Diabetes Mellitus, Type 1

Sweden
Diamyd Medical AB

Completed

Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes

Glucose Metabolism Disorders | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1 | Metabolic Disease | Vitamin D | Autoimmune Diabetes | Physiological Effects of Drugs | Juvenile Diabetes | Insulin Dependent Diabetes

Czechia, Netherlands, Spain, Sweden
Norwegian University of Science and Technology
Karolinska Institutet; Linkoeping University; St. Olavs Hospital; Diamyd Medical...

Completed

Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes (GADinLADA)

Latent Autoimmune Diabetes in Adults

Norway, Sweden
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Safety and Tolerability of Glatiramer Acetate (GLACIER)

Relapsing-Remitting Multiple Sclerosis

United States
Johnny Ludvigsson
Ostergotland County Council, Sweden; Diamyd Medical AB; Swedish Child Diabetes...

Completed

EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes

Diabetes Mellitus, Type 1

Sweden
Netherlands Institute for Pigment Disorders

Terminated

Fractional Laser Assisted Topical Anesthesia

Cicatrix

Netherlands
Netherlands Institute for Pigment Disorders
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Completed

Fractional Laser Assisted Delivery of Anesthetics III

Local Anesthesia of the Skin

Netherlands
Netherlands Institute for Pigment Disorders
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Completed

Fractional Laser Assisted Delivery of Anesthetics

Local Anesthesia of the Skin.

Netherlands
Netherlands Institute for Pigment Disorders

Completed

Fractional Laser Assisted Delivery of Anesthetics IIIb

Local Anesthesia of the Skin

Search clinical trials for: GAD-alum (Diamyd) 40 μg/mL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations